The major evidence review on this found insufficient evidence to establish whether compounded bioidentical hormone therapy is safe or effective for its prescribed uses, and every major relevant professional body, including obstetrics, endocrinology, and clinical pharmacy organizations, recommends FDA-approved products as first-line.

This isn't a chemistry problem, compounded products often contain the exact same molecules as regulated ones, it's a manufacturing quality problem: direct laboratory testing has found compounded products with actual doses far off from what was prescribed, including one pharmacy sample that delivered essentially no active hormone at all. The review identified only two narrow legitimate reasons for compounding: a documented allergy to a component of an FDA-approved product, or needing a dose or form that isn't commercially available, and it described both as rare.

What to know about this answer

Nearly every major guideline body agrees compounded hormone therapy should not be used routinely when an FDA-approved equivalent exists, but there are narrow, genuine situations, most clearly the total absence of an FDA-approved testosterone product for women, where compounding is a defensible clinical choice, not a fringe one.

What the research shows, and which source each finding rests on

A national evidence review found insufficient evidence to establish whether compounded bioidentical hormone therapy is safe or effective, based predominantly on low-quality sources like anecdotal claims and prescriber testimonies; it identified two narrow legitimate exceptions, documented allergy to an FDA-approved component, or a dosage form not commercially available, and described both as rare

A[1]

Ten randomly selected compounding pharmacies were given an identical prescription for testosterone gel or cream; only 50% of first-batch and 30% of second-batch samples were within plus-or-minus 20% of the prescribed dose, one pharmacy's samples contained virtually no testosterone at all (0.7% and 3.6% recovery), and commercial FDA-approved comparison products were consistently accurate (100-115% recovery)

D[2]

A retrospective comparison of 539 postmenopausal women found 57.6% of pellet-therapy users had a side effect versus 14.8% of FDA-approved-therapy users, and hysterectomy occurred in 20.3% of pellet users versus 6.3% of FDA-approved-therapy users

D[3]

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

Compounded hormone therapy should essentially never be used when an FDA-approved equivalent exists

Most clinicians in the field and every major guideline body reviewed

Direct laboratory testing found roughly half of compounded testosterone samples were off by more than 20% from the prescribed dose, with one pharmacy essentially delivering none of the active hormone; separately, pellet users had roughly four times the rate of side effects and three times the rate of hysterectomy compared with FDA-approved therapy users. Compounded products also lack the standard warning labels of pharmaceutical products, which one clinician describes as giving them the illusion of safety.

D[2]D[3]

There are narrow, real clinical uses for compounding

A minority position within the same field, focused specifically on testosterone

There is no FDA-approved testosterone product for women in the United States, so every woman treated with testosterone receives either a fractionally dosed male product or a compounded one; this fits squarely within the recognized exception for a dosage form not commercially available, and a preference for compounded testosterone on dosing-precision and cost grounds is a defensible clinical position. Access and cost are also real reasons some women turn to compounding, not simply gullibility.

A[1]

What would settle it: A randomized controlled trial comparing a specific compounded preparation against its FDA-approved equivalent, with clinical endpoints and long-term follow-up; no such trial is underway, and no commercial actor has an incentive to fund one.

What is really going on here

  1. Is this specific compounded product being used because of a documented allergy or an unavailable dose or form, the two narrow exceptions guideline bodies recognize, or for some other reason?
  2. Has this compounding pharmacy's products been independently tested for dose accuracy?
  3. Am I being told this is safer than FDA-approved therapy, a claim the major evidence review found unsupported?
  4. If this is a pellet, what happens if I have a side effect, given a pellet cannot be removed or down-titrated?

Questions for your doctor

  1. Is there an FDA-approved product that could meet my needs instead of a compounded one?
  2. If compounding is being recommended, which of the two recognized exceptions, allergy or unavailable dosage form, applies to me?
  3. How is this compounding pharmacy's dose accuracy and quality verified?
  4. What would we do if I had a side effect on this specific compounded product?
  5. Is this a pellet, and if so, am I comfortable with a therapy I cannot adjust or stop once it's in?

Questions with no answer yet

Is the absence of a randomized trial comparing a specific compounded preparation against its FDA-approved equivalent because compounded products are known to be equivalent, or because no commercial actor has an incentive to fund the trial that would settle it?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The major evidence review found insufficient evidence to establish safety or efficacy for compounded bioidentical hormone therapy, based predominantly on low-quality sources like anecdotal claims and prescriber testimonies. No randomized trial comparing a specific compounded preparation against its FDA-approved equivalent exists, and no commercial actor has an incentive to fund one.

What would test it: A randomized controlled trial comparing a specific compounded preparation against its FDA-approved equivalent, with clinical endpoints and long-term follow-up, funded independently of any compounding pharmacy or manufacturer.

Does compounding quality vary meaningfully by pharmacy, molecule, or region, or was the dose-accuracy problem found in the testosterone study a broader pattern across all compounded hormones?

Partly studied

What is known: The direct laboratory dose-accuracy testing was done specifically on compounded testosterone gel and cream from ten pharmacies in one metropolitan area; the source material does not report an equivalent study for compounded estradiol or progesterone specifically.

What would test it: A comparable laboratory dose-accuracy study of compounded estradiol and progesterone products across multiple pharmacies and regions.

Sources

  1. 1.National Academies of Sciences, Engineering, and Medicine. The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use. Washington DC: National Academies Press, 2020.Systematic review or guideline
  2. 2.Accuracy of testosterone concentrations in compounded testosterone products.Grober ED, Garbens A, Bozovic A, Kulasingam V, Fanipour M, Diamandis EP. Accuracy of testosterone concentrations in compounded testosterone products. J Sex Med 2015;12(6):1381-1388. · Comparative or small study
  3. 3.Safety assessment of compounded non-FDA-approved hormonal therapy versus FDA-approved hormonal therapy in treating postmenopausal women.Jiang X, Bossert A, Parthasarathy KN, Leaman K, Minassian SS, Schnatz PF, Woodland MB. Safety assessment of compounded non-FDA-approved hormonal therapy versus FDA-approved hormonal therapy in treating postmenopausal women. Menopause 2021;28(8):867-874. · Comparative or small study

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions

Related guides